Postmarketing study of cardiovascular adverse reactions associated with sumatriptan
about
Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data.Antidepressant drugs and the cardiovascular system: a comparison of tricylics and selective serotonin reuptake inhibitors and their relevance for the treatment of psychiatric patients with cardiovascular problems.Vascular effects of the new anti-migraine agent almotriptan on human cranial and peripheral arteries.
P2860
Postmarketing study of cardiovascular adverse reactions associated with sumatriptan
description
1993 nî lūn-bûn
@nan
1993 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Postmarketing study of cardiovascular adverse reactions associated with sumatriptan
@ast
Postmarketing study of cardiovascular adverse reactions associated with sumatriptan
@en
Postmarketing study of cardiovascular adverse reactions associated with sumatriptan
@nl
type
label
Postmarketing study of cardiovascular adverse reactions associated with sumatriptan
@ast
Postmarketing study of cardiovascular adverse reactions associated with sumatriptan
@en
Postmarketing study of cardiovascular adverse reactions associated with sumatriptan
@nl
prefLabel
Postmarketing study of cardiovascular adverse reactions associated with sumatriptan
@ast
Postmarketing study of cardiovascular adverse reactions associated with sumatriptan
@en
Postmarketing study of cardiovascular adverse reactions associated with sumatriptan
@nl
P2093
P2860
P1433
P1476
Postmarketing study of cardiovascular adverse reactions associated with sumatriptan
@en
P2093
B H Stricker
H A Valkenburg
J P Ottervanger
T B van Witsen
P2860
P356
10.1136/BMJ.307.6913.1185
P407
P577
1993-11-06T00:00:00Z